Edith Wood

COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGED ANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS

Robert Altman, L Carreras, Rubén Sierra Díaz et al. · Oxford University Research Archive (ORA) (University of Oxford) · 1994 · 3.3K citations

Medicine, Pharmacology, Pharmacotherapy +10

Effects of antiplatelet therapy after stroke due to intracerebral haemorrhage (RESTART): a randomised, open-label trial

Rustam Al‐Shahi Salman, M. J. S. Dennis, PAG Sandercock et al. · The Lancet · 2019 · 195 citations · Full text

Medicine, Hematology, Pharmacotherapy +17

Effects of antiplatelet therapy on stroke risk by brain imaging features of intracerebral haemorrhage and cerebral small vessel diseases: subgroup analyses of the RESTART randomised, open-label trial

Rustam Al‐Shahi Salman, David Minks, Dipayan Mitra et al. · The Lancet Neurology · 2019 · 89 citations · Full text

Medicine, Neurology, Pharmacotherapy +17

Reversal strategies for vitamin <scp>K</scp> antagonists in acute intracerebral hemorrhage

Adrian Parry‐Jones, Mario Di Napoli, Joshua N. Goldstein et al. · Annals of Neurology · 2015 · 87 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Effects of Antiplatelet Therapy After Stroke Caused by Intracerebral Hemorrhage

Rustam Al‐Shahi Salman, Martin Dennis, Peter Sandercock et al. · JAMA Neurology · 2021 · 48 citations · Full text

Medicine, Neurology, Pharmacotherapy +17